Envoy Medical, Inc.
Close on Oct 19, 2026
- Market cap
- $68.04M
- P/E (TTM)
- –
- Dividend yield
- –
About Envoy Medical
Orthopedic, Prosthetic & Surgical Appliances & Supplies, SIC 3842
Envoy Medical, Inc. is a hearing health medical device company that develops implantable hearing technologies designed to utilize the natural anatomy of the ear. The company focuses on developing electrical and mechanical hearing systems across the hearing loss spectrum. Its key product development includes the Acclaim cochlear implant, a fully implanted investigational system featuring an implanted sensor, sound processor, and power source that captures sound without external, ear-worn components. The company also developed the Esteem fully implanted active middle ear implant. Its devices are designed for adult patients suffering from hearing loss, specifically targeting individuals with severe-to-profound sensorineural hearing loss who obtain limited benefit from conventional hearing aids.
The company operates in the medical device sector and conducts clinical trial activities in the United States, where approximately 1,000 of its middle ear devices have been implanted globally. Envoy Medical maintains its principal executive offices and headquarters in White Bear Lake, Minnesota.
Summary of the business section of Envoy Medical's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Envoy Medical, Inc.
- Headquarters
- White Bear Lake, MN
- Address
- 4875 White Bear Parkway 55110
- Phone
- (651) 361-8000
- Website
- envoymedical.com
- Employees
- 43, Dec 31, 2025
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Fiscal year ends
- December 31
- Auditor
- GRANT THORNTON LLP, Fort Lauderdale, Florida
Stock & identifiers
- Ticker
- COCH
- Other tickers
- COCHW
- Exchange
- Nasdaq
- IPO date
- Mar 3, 2021
- Shares outstanding
- 77M, Aug 10, 2026
- Public float
- $12.70M, Dec 31, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1840877
- CUSIP
- 29415V109
- ISIN
- US29415V1098
- EIN
- 86-1369123
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Brent T. Lucas | Chief Executive Officer, Director | 342,666 |
| Robert Potashnick | CAO & VP of Finance | 212,500 |
| Chas McKhann | Director | – |
| Charles Brynelsen | Director | 1,050,000 |
| Mona Chetan Patel | Director | 332,500 |
| Susan Kantor | Director | 174,037 |
| Michael Curtis Crowe | Director | – |
| Janis Smith-Gomez | Director | – |
Employees
Headcount reported in annual reports
“2025, we had approximately 43 full time employees and 4 part time employees.”
Corporate history
Events identified from SEC filings